A NEW series of 2,4-disubstituted phthalazin-1(2H)-one derivatives were synthesized via nucleophilic attach of N-2 of phthalazin-1(2H)-one derivatives on different monosuccharides. Synthesis of phthalazinone nucleosides were very effective as antimicrobial. Also the phthalazinone moiety can be used in synthesis of reactive nucleosides and dyes that were chemically bonded with proteins and fibers respectively as afforded highly stability of dyestuff wool and cotton textiles. The structure of the prepared compounds was elucidated by physical and spectral data like FT-IR, 1 H-and 13 C-NMR.

Composites of emeraldine form of polyaniline (PAni) and poly(methyl methacrylate) (PMMA) are prepared by emulsion polymerization method in definite ratios. The chemical structure of the samples and their morphologies have been investigated by different techniques including FTIR, UV-vis, XRD, SEM, and TGA. Enhancement in thermal stability of the obtained composites by PAni additions has been confirmed. Alpha analyzer, in frequency range 0.1 Hz to 20 MHz, was employed to investigate the molecular dynamics of the prepared samples and the accompanied electrical conductivity at temperatures ranging from 223 to 423 K. Conductivity investigations showed that mobility has the more dominant effect on the charge transportation. The dynamic peak at lower temperatures of the PMMA has high activation energy (83.8 kJ/mol). While, Maxwill-Wagner-Siller process due to the interfacial polarization in the composites has only 7.5 kJ/mol activation energy. This is a clear indication of the ease of the investigated dynamic.

Background The coronavirus disease 2019 pandemic has resulted in a growing population of individuals who experience a wide range of persistent symptoms referred to as “long COVID.” Symptoms include neurocognitive impairment and fatigue. Two potential mechanisms could be responsible for these long-term unremitting symptoms: hypercoagulability, which increases the risk of blood vessel occlusion, and an uncontrolled continuous inflammatory response. Currently, no known treatment is available for long COVID. One of the options to reverse hypoxia, reduce neuroinflammation, and induce neuroplasticity is hyperbaric oxygen therapy. In this article, we present the first case report of a previously healthy athletic individual who suffered from long COVID syndrome treated successfully with hyperbaric oxygen therapy. Case presentation A previously healthy 55-year-old Caucasian man presented 3 months after severe coronavirus disease 2019 infection with long COVID syndrome. His symptoms included a decline in memory, multitasking abilities, energy, breathing, and physical fitness. After evaluation that included brain perfusion magnetic resonance imaging, diffusion tensor imaging, computerized cognitive tests, and cardiopulmonary test, he was treated with hyperbaric oxygen therapy. Each session included exposure to 90 minutes of 100% oxygen at 2 atmosphere absolute pressure with 5-minute air breaks every 20 minutes for 60 sessions, 5 days per week. Evaluation after completing the treatment showed significant improvements in brain perfusion and microstructure by magnetic resonance imaging and significant improvement in memory with the most dominant effect being on nonverbal memory, executive functions, attention, information procession speed, cognitive flexibility, and multitasking. The improved cognitive functions correlated with the increased cerebral blood flow in brain regions as measured by perfusion magnetic resonance imaging. With regard to physical capacity, there was a 34% increase in the maximum rate of oxygen consumed during exercise and a 44% improvement in forced vital capacity. The improved physical measurements correlated with the regain of his pre-COVID physical capacity. Conclusions We report the first case of successfully treated long COVID symptoms with hyperbaric oxygen therapy with improvements in cognition and cardiopulmonary function. The beneficial effects of hyperbaric oxygen shed additional light on the pathophysiology of long COVID. As this is a single case report, further prospective randomized control studies are needed.

No abstract

No abstract